DRUGphase2small molecule
Ignaseclant
Brand names: NMD670
Mechanism
ClC-1 (CLCN1) skeletal-muscle chloride channel inhibitor — improves muscle function as an adjunct to SMN-restoring therapy
Related claims (0)
No claims matched “Ignaseclant” in free-text search.
Off-Target Findings (0)
No Boltz-2 / Chai-1 off-target panel claims recorded for this drug.